Richmond Pharmacology is excited to join the PNS Congress 2026 in Maastricht, The Netherlands, on 12- 15 June 2026.

Bringing together global leaders in peripheral nerve research and clinical care, this meeting serves as a key platform for advancing understanding of neuromuscular disorders, accelerating therapeutic innovation, and fostering collaboration between academia, industry, and patient organizations.

Representing Richmond Pharmacology

Dr Jörg Taubel, Chief Executive Officer

We look forward to connecting with attendees to discuss Richmond’s expertise in:

  • Advances in peripheral nerve disorder research and treatment
  • Translational approaches for early-phase drug development
  • Regulatory considerations for innovative therapies
  • Patient-centric trial design and recruitment strategies
  • Strengthening partnerships across academia, industry, and advocacy groups

Connect With Us

If you are attending the PNS Annual Meeting 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

‍

Latest news

The Future of Cardiometabolic Research: Five Questions Shaping the Next Decade

October 22, 2026
Cardiometabolic research is continually evolving beyond explanations centred on single causes of disease.
Read more

Upcoming Event

AASLD

05 - 09 November 2026
Richmond Pharmacology is excited to join the AASLD Emerging Topic Conference: Unified Frontiers in Liver Disease in Denver, USA, on 05– 09 November 2026.
View event